Jiangsu Hengrui Medicine Co., Ltd.;Shanghai Hengrui Pharmaceutical Co., Ltd.
发明人:
Hua Ying,Jinping Shi,Ylfang Wang,Qiyue Hu,Hu Ge,Weikang Tao
申请号：
US16651639
公开号：
US20200262909A1
申请日:
2018.09.28
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided are an IL-5 antibody, an antigen binding fragment thereof, and a medical application therefor. The present invention comprises a mouse-derived antibody containing an IL-5 antibody CDR region, a chimeric antibody, a humanized antibody, and a pharmaceutical composition comprising said IL-5 antibody and said antigen binding fragment thereof, as well as the use of the pharmaceutical composition as a drug.
